BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 33939274)

  • 41. The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma.
    Cui M; Sun J; Hou J; Fang T; Wang X; Ge C; Zhao F; Chen T; Xie H; Cui Y; Yao M; Li J; Li H
    Tumour Biol; 2016 Oct; 37(10):13521-13531. PubMed ID: 27465557
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells.
    Herwig N; Belter B; Wolf S; Haase-Kohn C; Pietzsch J
    J Cell Mol Med; 2016 May; 20(5):825-35. PubMed ID: 26928771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. miR‑590‑5p inhibits tumor growth in malignant melanoma by suppressing YAP1 expression.
    Mou K; Ding M; Han D; Zhou Y; Mu X; Liu W; Wang L
    Oncol Rep; 2018 Oct; 40(4):2056-2066. PubMed ID: 30106445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PA-MSHA inhibits the growth of doxorubicin-resistant MCF-7/ADR human breast cancer cells by downregulating Nrf2/p62.
    Wei Y; Liu D; Jin X; Gao P; Wang Q; Zhang J; Zhang N
    Cancer Med; 2016 Dec; 5(12):3520-3531. PubMed ID: 27758045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ephrin-A2 promotes prostate cancer metastasis by enhancing angiogenesis and promoting EMT.
    Zhao Y; Cai C; Zhang M; Shi L; Wang J; Zhang H; Ma P; Li S
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):2013-2023. PubMed ID: 33772606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
    Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs.
    Hämäläinen M; Teppo HR; Skarp S; Haapasaari KM; Porvari K; Vuopala K; Kietzmann T; Karihtala P
    Oxid Med Cell Longev; 2019; 2019():2647068. PubMed ID: 31687076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
    Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-605 functions as a tumor suppressor by targeting INPP4B in melanoma.
    Chen L; Cao Y; Rong D; Wang Y; Cao Y
    Oncol Rep; 2017 Aug; 38(2):1276-1286. PubMed ID: 28656250
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
    Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
    J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells.
    Rocha CR; Kajitani GS; Quinet A; Fortunato RS; Menck CF
    Oncotarget; 2016 Jul; 7(30):48081-48092. PubMed ID: 27344172
    [TBL] [Abstract][Full Text] [Related]  

  • 54. KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth.
    Riverso M; Montagnani V; Stecca B
    Oncogene; 2017 Jun; 36(23):3322-3333. PubMed ID: 28068326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
    Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM
    Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of CDKN2A (p16INK4A/p14ARF) Over-Expression on Proliferation and Migration of Human Melanoma A375 Cells.
    Bai M; Yu NZ; Long F; Feng C; Wang XJ
    Cell Physiol Biochem; 2016; 40(6):1367-1376. PubMed ID: 27997910
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Testis-specific expression of rat mitochondrial glycerol-3-phosphate dehydrogenase in haploid male germ cells.
    Weitzel JM; Shiryaeva NB; Middendorff R; Balvers M; Radtke C; Ivell R; Seitz HJ
    Biol Reprod; 2003 Feb; 68(2):699-707. PubMed ID: 12533437
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder Cancer.
    Mokkapati S; Porten SP; Narayan VM; Lim AH; Jayaratna IS; Roth B; Cheng T; Navai N; Wszolek M; Melquist J; Manyam G; Choi W; Broom B; Pretzsch S; Czerniak B; McConkey DJ; Dinney CPN
    Mol Cancer Res; 2020 Jun; 18(6):811-821. PubMed ID: 32122956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of mitochondrial and/or cytosolic glycerol 3-phosphate dehydrogenase overexpression on glucose-stimulated insulin secretion from MIN6 and HIT cells.
    Ishihara H; Nakazaki M; Kanegae Y; Inukai K; Asano T; Katagiri H; Yazaki Y; Kikuchi M; Miyazaki J; Saito I; Oka Y
    Diabetes; 1996 Sep; 45(9):1238-44. PubMed ID: 8772729
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.